The Ward Without Walls: Point-of-Care Testing in UK Care Homes

A different kind of clinical space

Consider a composite scenario. An 86-year-old care home resident with advanced frailty becomes more breathless over 24 hours. The staff know her well. They also know that a hospital admission could leave her more confused, more dependent and further from home. In a service with point-of-care testing, a nurse records her oxygen saturation, takes a small blood sample for a CRP result and tests for influenza and COVID-19. The GP reviews the findings by video and decides whether to treat in the home, arrange urgent community support or send her to hospital.

This is not a miniature hospital. It is a supported clinical decision in the place the resident lives. That distinction matters. The next diagnostic revolution in the UK may not arrive as a new scanner in a teaching hospital. It may arrive as a reliable pathway for rapid testing in care homes, with the training and governance to make the result useful.

Why care homes are a natural diagnostic setting

Care homes already manage a great deal of clinical risk. Residents are often frail, have multiple long-term conditions and present atypically. Infection may show as confusion rather than fever. Dehydration may look like drowsiness. A delayed diagnosis can lead to an emergency admission that might have been avoided with earlier treatment.

Point-of-care testing has expanded accordingly. Depending on the home and the local service, it can include CRP, influenza and COVID-19 tests, urine dipsticks, blood glucose monitoring, anticoagulation checks and basic observations such as pulse oximetry. None of these is a diagnosis on its own. Together, they can help a GP or community team decide what to do next, and they can give care staff a language for escalation.

The attraction is obvious. Tests close to the resident can reduce travel, shorten the time to treatment and support antibiotic stewardship when used well. They can also reduce the number of older people sent to emergency departments for investigations that could have been done at the bedside.

What the pilots suggest, and what they do not

Several UK pilots have reported reductions in avoidable emergency department attendance and faster treatment decisions when rapid testing is embedded in a clear clinical pathway. NHS England's urgent community response and virtual ward models have shown similar interest in keeping care closer to home. The evidence base is promising, but it is not yet uniform. Studies are often small, local and shaped by the enthusiasm of a particular team.

That matters for adoption. A test that works in a well-staffed research pilot may not work in a home with high staff turnover, limited space and no dedicated clinical lead. The question is not simply whether point-of-care testing can improve care. It is what has to be true for it to do so reliably.

The barriers are mainly operational

The technology is often the easy part. The harder parts are human and organisational.

• Training and confidence. Care staff need more than a single session. They need competency assessment, refresher training and a clear understanding of what a result does and does not mean.
• Device maintenance and quality assurance. Machines need calibration, consumables, temperature control and documentation. Without that, a result is not a result; it is a number.
• Funding and commissioning. Devices are visible. Consumables, staff time, training and governance are less visible and more easily ignored.
• Data integration. Results need to reach the GP record and the care home record without duplicate entry or lost documentation.
• Consent and capacity. Frail residents may lack capacity to consent to a test. Advance care plans and best-interest decisions must be part of the pathway, not an afterthought.
• Antibiotic stewardship. A CRP result can support a decision, but it can also be treated as a permission slip for antibiotics. The clinical conversation still matters.
• GP workload. Rapid testing should not simply shift work to general practice without resourcing the review, advice and follow-up that make it safe.
• Regulation and governance. Care Quality Commission expectations, infection prevention and incident reporting all need to be built into the service design.

Five conditions for routine use

If care-home diagnostics are to move from exceptional pilots to routine care, five conditions stand out.

1. A commissioned pathway with a named clinical lead. The test must belong to a service, not to a cupboard. Someone must be accountable for results, escalation and review.
2. A competency framework for care staff. Training should cover sample collection, device use, infection control, documentation and escalation. It should be assessed, not assumed.
3. Quality assurance and device management. Homes need a simple system for calibration, consumables, fault reporting and audit. This is unglamorous and essential.
4. Interoperability and documentation. Results should flow into the records used by GPs, community teams and care home staff. A fax or a phone call is not interoperability.
5. Evaluation and equitable funding. Commissioners should fund consumables and staff time, not just equipment, and should evaluate outcomes across different types of home and community.

The test is not the decision

A normal CRP does not rule out serious illness. A negative influenza test does not explain breathlessness. A urine dipstick in a frail older person may reflect colonisation rather than infection. Point-of-care testing is most useful when it is interpreted alongside the patient's history, observations, goals of care and advance care plan.

That is why care-home diagnostics should be framed as clinical testing literacy, not just equipment rollout. Staff need to understand pre-test probability, false results and the limits of a single reading. Clinicians need to know when not to test, and when to act on a clinical impression despite a reassuring number.

The quiet revolution

The most significant change may be cultural. A care home that can test, document and escalate confidently is a care home that can participate more fully in clinical decision-making. It is not trying to become a hospital. It is trying to make sure that a frail resident gets the right assessment in the right place, with the least disruption and the greatest chance of returning to the life they know.

That is a modest ambition, and a serious one. The ward without walls will not be built by devices alone. It will be built by training, funding, governance and a shared understanding that a test is only as good as the pathway around it.